Telix Launches New Prostate Cancer Imaging Agent, Gozellix, in U.S.

Go back to Telix Launches New Prostate Cancer Imaging Agent, Gozellix, in U.S.
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 12.00 +0.21 (1.78%)
Previous Close $11.79    52 Week High $2.18 
Open $11.98    52 Week Low $0.30 
Day High $12.04    P/E N/A 
Day Low $11.92    EPS $-3.32 
Volume 81,750       

TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 12.00 +0.21 (1.78%)
Previous Close $11.79    52 Week High $2.18 
Open $11.98    52 Week Low $0.30 
Day High $12.04    P/E N/A 
Day Low $11.92    EPS $-3.32 
Volume 81,750